Researchers have identified previously ignored mutations that, despite being rare, are likely associated with cancer growth. The discovery may lead to the development of new targeted therapies.
The largest-known study in thyroid cancer patients highlights that skeletal complications in high-risk follicular and medullary thyroid cancer patients are an indicator of poor prognosis.
A recent study has demonstrated the potential link between concentration of fine air particle pollution and breast density.
This article outlines the importance of homologous recombination repair pathway in development of breast carcinoma (BC), and the influence of gene alterations in chemotherapy treated BC samples.
This review focuses on the development and advantages of DNA damaging combi-molecules, followed by future opportunities and challenges in there discovery.
What are the current limitation with clinical trials for AML? This review discusses trial end points, patient enrollment, cost of drug discovery and patient heterogeneity and future treatment of AML.